Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Defends Right Not To Publish Clinical Trials

This article was originally published in The Pink Sheet Daily

Executive Summary

Merck believes clinical trial disclosure rules must distinguish between hypothesis-generating and hypothesis-testing trials.

You may also be interested in...



Medical Journals To Require Registration Of All Controlled Trials On ClinicalTrials.gov

The International Committee of Medical Journal Editors will require that studies be registered at or before patient enrollment in order to be considered for publication. A Sept. 9 editorial notes that only ClinicalTrials.gov currently fits ICMJE registry criteria.

Medical Journals To Require Registration Of All Controlled Trials On ClinicalTrials.gov

The International Committee of Medical Journal Editors will require that studies be registered at or before patient enrollment in order to be considered for publication. A Sept. 9 editorial notes that only ClinicalTrials.gov currently fits ICMJE registry criteria.

Medical Journals To Propose Making Trial Registry Condition For Publication

International Committee of Medical Journal Editors will publish an editorial Sept. 9 proposing to make clinical trial registration a prerequisite for later publication. Merck exec highlights concerns with “assumption of...surreptitious behavior” that is behind the proposal.

Topics

UsernamePublicRestriction

Register

LL1133951

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel